Boston Scientific Corporation ( NYSE: BSX) TD Cowen 45th Annual Healthcare Conference March 4, 2025 9:10 AM ET Dan Brennan - Chief Financial Officer Ken Stein - Chief Medical Officer Art Butcher - ...

Johnson & Johnson (NYSE:JNJ) 45th Annual TD Cowen Healthcare Conference March 4, 2025 11:10 AM ETCompany ParticipantsTim Schmid - Executive ...

Boston Scientific Corp. closed 9.34% short of its 52-week high of $107.17, which the company reached on February 5th.

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Umpires_Home, James Jean; First, Ron Kulpa; Second, Hunter Wendelstedt; Third, Shane Livensparger. T_2:38. A_5,315 (6,871).

Marlborough medical device manufacturer Boston Scientific has entered into a purchase agreement worth up to half a billion ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Shares of Boston Scientific Corp. BSX slipped 1.66% to $99.13 Friday, on what proved to be an all-around great trading ...

In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

C Medical Technologies announced today that it closed a Series D financing round resulting in gross proceeds of up to $175 ...

Boston Scientific has gained a duo of CE markings in the European Union (EU) for its navigation enabled Farawave NAV Ablation Catheter for paroxysmal atrial fibrillation (AF) treatment and its new ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.